Suggestions

Du même auteur

L’istradefylline (KW6002), un antagoniste sélectif du récepteur A2A (A2AR), limite les effets toxiques du cisplatine tout en préservant ses propriétés anti-tumorales

Archive ouverte | Fellah, Sandy | CCSD

International audience

Istradefylline protects from cisplatin-induced nephrotoxicity and peripheral neuropathy while preserving cisplatin antitumor effects

Archive ouverte | Dewaeles, Edmone | CCSD

International audience. Cisplatin is a potent chemotherapeutic drug that is widely used in the treatment of various solid cancers. However, its clinical effectiveness is strongly limited by frequent severe adverse e...

Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicity

Archive ouverte | Larrue, Romain | CCSD

International audience. Abstract Variability in genes involved in drug pharmacokinetics or drug response can be responsible for suboptimal treatment efficacy or predispose to adverse drug reactions. In addition to c...

Chargement des enrichissements...